{"id":"placebo-of-cilostazol","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL799","moleculeType":"Small molecule","molecularWeight":"369.47"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"A placebo of cilostazol contains no active drug substance and produces no direct pharmacological effect. It is used as a control in clinical trials to assess the efficacy of the actual cilostazol drug by comparison. Any observed effects in placebo recipients are attributable to placebo response rather than drug action.","oneSentence":"This is a placebo formulation with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:13.102Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06757764","phase":"PHASE4","title":"The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2025-07-10","conditions":"Cerebral Infarction, Stenosis Artery","enrollment":2340},{"nctId":"NCT07286110","phase":"PHASE1","title":"Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES Trial","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-12-30","conditions":"Moyamoya Disease, Moyamoya Syndrome","enrollment":66},{"nctId":"NCT07238985","phase":"PHASE1, PHASE2","title":"Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-11-01","conditions":"Fatty Liver","enrollment":50},{"nctId":"NCT03855332","phase":"PHASE2","title":"Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-07-11","conditions":"Small Vessel Cerebrovascular Disease","enrollment":75},{"nctId":"NCT07174414","phase":"PHASE3","title":"Cilostazol for Prevention of Recurrent Stroke Trial","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2026-08","conditions":"Stroke Recurrence, Myocardial Infarction, Vascular Death","enrollment":2000},{"nctId":"NCT07144956","phase":"PHASE3","title":"Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier St Anne","startDate":"2025-12-15","conditions":"Aneurysmal Subarachnoid Hemorrhage","enrollment":630},{"nctId":"NCT04789837","phase":"PHASE1, PHASE2","title":"The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis","status":"WITHDRAWN","sponsor":"Sadat City University","startDate":"2021-03-01","conditions":"Osteoarthritis","enrollment":""},{"nctId":"NCT04761848","phase":"PHASE1, PHASE2","title":"Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease","status":"WITHDRAWN","sponsor":"Sadat City University","startDate":"2021-02-16","conditions":"Fatty Liver, Nonalcoholic","enrollment":""},{"nctId":"NCT04410341","phase":"PHASE1, PHASE2","title":"The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients","status":"WITHDRAWN","sponsor":"Sadat City University","startDate":"2020-05-01","conditions":"Major Depressive Disorder","enrollment":""},{"nctId":"NCT07040085","phase":"PHASE3","title":"Y-6 Sublingual Tablets for Patients With Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-08-05","conditions":"Stroke","enrollment":892},{"nctId":"NCT06989697","phase":"PHASE3","title":"Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes","status":"RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2025-01-01","conditions":"Type 2 Diabets Mellitus, Cognitive Ability, General","enrollment":80},{"nctId":"NCT02098460","phase":"PHASE4","title":"To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject","status":"COMPLETED","sponsor":"Otsuka Beijing Research Institute","startDate":"2013-10","conditions":"Severe Hypercholesterolemia","enrollment":300},{"nctId":"NCT06886620","phase":"PHASE3","title":"Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent Claudication","status":"TERMINATED","sponsor":"Genovate Biotechnology Co., Ltd.,","startDate":"2016-03-14","conditions":"Intermittent Claudication","enrollment":14},{"nctId":"NCT06612593","phase":"PHASE2","title":"Cilostazol in Parkinson's Disease","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2024-10-01","conditions":"Parkinson's Disease","enrollment":50},{"nctId":"NCT04148105","phase":"PHASE4","title":"Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)","status":"TERMINATED","sponsor":"Henry Ford Health System","startDate":"2019-11-01","conditions":"Aneurysmal Subarachnoid Hemorrhage","enrollment":19},{"nctId":"NCT05594680","phase":"PHASE3","title":"Cilostazol and Methotrexate in Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2022-10-01","conditions":"Rheumatoid Arthritis","enrollment":70},{"nctId":"NCT06138834","phase":"PHASE2","title":"EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2023-11","conditions":"Acute Ischemic Stroke, Large Vessel Occlusion, Reperfusion","enrollment":300},{"nctId":"NCT05836766","phase":"PHASE2","title":"Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel Occlusion","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2023-06-05","conditions":"Acute Ischemic Stroke, Reperfusion, Large Vessel Occlusion","enrollment":120},{"nctId":"NCT05298696","phase":"PHASE1, PHASE2","title":"Efficacy of Cilostazol in Prevention of Peripheral Neuropathy","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2022-03-28","conditions":"Peripheral Neuropathy, Breast Cancer","enrollment":71},{"nctId":"NCT05595993","phase":"NA","title":"Hypersensitivity to Phosphodiesterase 3 Inhibition in Post-Traumatic Headache","status":"UNKNOWN","sponsor":"Danish Headache Center","startDate":"2022-10-25","conditions":"Post-Traumatic Headache","enrollment":21},{"nctId":"NCT04069819","phase":"NA","title":"The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder.","status":"COMPLETED","sponsor":"Sadat City University","startDate":"2019-08-01","conditions":"Major Depressive Disorder","enrollment":80},{"nctId":"NCT01142284","phase":"PHASE2","title":"Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety","status":"COMPLETED","sponsor":"Korea Otsuka Pharmaceutical Co., Ltd.","startDate":"2010-05-19","conditions":"Peripheral Artery Disease","enrollment":80},{"nctId":"NCT00766545","phase":"PHASE3","title":"Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Co., Ltd.","startDate":"1992-04","conditions":"Cerebral Infarction","enrollment":1095},{"nctId":"NCT02491268","phase":"PHASE2","title":"A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)","status":"COMPLETED","sponsor":"National Cerebral and Cardiovascular Center, Japan","startDate":"2015-05-01","conditions":"Mild Cognitive Impairment","enrollment":166},{"nctId":"NCT04452929","phase":"NA","title":"The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients","status":"UNKNOWN","sponsor":"Danish Headache Center","startDate":"2020-07-22","conditions":"Migraine, Migraine Without Aura, Migraine With Aura","enrollment":72},{"nctId":"NCT04407312","phase":"PHASE4","title":"Cilostazol and Endothelial Progenitor Cell","status":"UNKNOWN","sponsor":"Gyeongsang National University Hospital","startDate":"2016-01-01","conditions":"Myocardial Infarction, Acute","enrollment":60},{"nctId":"NCT03422796","phase":"NA","title":"The Effect of Sumatriptan and Placebo Injection on Cilostazol Induced Headache","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2017-11-01","conditions":"Migraine","enrollment":30},{"nctId":"NCT00822172","phase":"PHASE4","title":"Evaluation of Cilostazol in Combination With L-Carnitine","status":"COMPLETED","sponsor":"Colorado Prevention Center","startDate":"2008-09","conditions":"Peripheral Vascular Disease, Intermittent Claudication, Peripheral Arterial Disease","enrollment":164},{"nctId":"NCT03190005","phase":"","title":"Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity)","status":"COMPLETED","sponsor":"Taipei City Hospital","startDate":"2017-01-01","conditions":"Stable Angina","enrollment":35},{"nctId":"NCT03318276","phase":"PHASE3","title":"Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2017-02-20","conditions":"Peripheral Arterial Disease","enrollment":170},{"nctId":"NCT00443287","phase":"PHASE2","title":"Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease","status":"COMPLETED","sponsor":"Sanofi","startDate":"2007-02","conditions":"Intermittent Claudication","enrollment":553},{"nctId":"NCT03156920","phase":"NA","title":"Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2017-05-23","conditions":"Migraine","enrollment":30},{"nctId":"NCT02486276","phase":"NA","title":"The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2015-06","conditions":"Migraine","enrollment":30},{"nctId":"NCT02087007","phase":"PHASE3","title":"A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina","status":"COMPLETED","sponsor":"Korea Otsuka Pharmaceutical Co., Ltd.","startDate":"2013-11","conditions":"Vasospastic Angina","enrollment":100},{"nctId":"NCT03116269","phase":"PHASE4","title":"The Effect of Cilostazol Compared to Aspirin on Endothelial Function in Acute Cerebral Ischemia Patients","status":"COMPLETED","sponsor":"Ajou University School of Medicine","startDate":"2012-03-01","conditions":"Ischemic Stroke, Endothelial Dysfunction","enrollment":80},{"nctId":"NCT01895400","phase":"PHASE3","title":"Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy","status":"TERMINATED","sponsor":"Jong Woo Chung","startDate":"2013-07","conditions":"Recurrent Vestibulopathy","enrollment":26},{"nctId":"NCT02483169","phase":"PHASE4","title":"PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2009-06","conditions":"Brain Ischemia, Intracranial Hemorrhages","enrollment":800},{"nctId":"NCT01013532","phase":"PHASE4","title":"PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2009-06","conditions":"Brain Ischemia, Intracranial Hemorrhages","enrollment":1600},{"nctId":"NCT01346865","phase":"PHASE4","title":"Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)","status":"TERMINATED","sponsor":"Seung-Jung Park","startDate":"2011-05","conditions":"Coronary Artery Disease","enrollment":402},{"nctId":"NCT02194686","phase":"PHASE4","title":"Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in High Risk for Cardiovascular Disease","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2013-01","conditions":"Cardiovascular Diseases","enrollment":71},{"nctId":"NCT02174939","phase":"PHASE4","title":"Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease","status":"UNKNOWN","sponsor":"National Cheng-Kung University Hospital","startDate":"2014-02","conditions":"Coronary Artery Disease","enrollment":300},{"nctId":"NCT02253004","phase":"EARLY_PHASE1","title":"Induction of Migraine Aura With Cilostazol","status":"COMPLETED","sponsor":"Herlev Hospital","startDate":"2014-09","conditions":"Migraine With Aura, Stroke","enrollment":16},{"nctId":"NCT01952756","phase":"PHASE4","title":"Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2012-01","conditions":"Peripheral Arterial Diseases","enrollment":44},{"nctId":"NCT01841827","phase":"NA","title":"The Headache Inducing Effects of Cilostazol on Migraine Patients","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2013-04","conditions":"Migraine","enrollment":14},{"nctId":"NCT01378650","phase":"NA","title":"A Study on the Effect of Cilostazol in Patients With Chronic Tinnitus","status":"COMPLETED","sponsor":"Jong Woo Chung","startDate":"2011-07","conditions":"Tinnitus","enrollment":50},{"nctId":"NCT01188824","phase":"PHASE4","title":"The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)","status":"COMPLETED","sponsor":"China Medical University Hospital","startDate":"2010-09","conditions":"Ischemic Stroke","enrollment":801},{"nctId":"NCT01444885","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina","status":"COMPLETED","sponsor":"Korea Otsuka Pharmaceutical Co., Ltd.","startDate":"2011-10","conditions":"Variant Angina","enrollment":50},{"nctId":"NCT00783081","phase":"PHASE2","title":"Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication","status":"COMPLETED","sponsor":"Kowa Research Institute, Inc.","startDate":"2008-11","conditions":"Intermittent Claudication","enrollment":387},{"nctId":"NCT00741286","phase":"PHASE4","title":"Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler","status":"COMPLETED","sponsor":"Inje University","startDate":"2006-11","conditions":"Cerebral Infarction","enrollment":203},{"nctId":"NCT01031667","phase":"PHASE4","title":"Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study)","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2009-11","conditions":"Therapy","enrollment":118},{"nctId":"NCT00234065","phase":"PHASE4","title":"Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Co., Ltd.","startDate":"2003-12","conditions":"Cerebral Infarction","enrollment":2800},{"nctId":"NCT00589927","phase":"PHASE4","title":"Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent","status":"COMPLETED","sponsor":"CardioVascular Research Foundation, Korea","startDate":"2007-12","conditions":"Coronary Artery Disease","enrollment":486},{"nctId":"NCT00446641","phase":"PHASE4","title":"Overcome Biochemical Aspirin Resistance Through Cilostazol Combination","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2007-03","conditions":"Cerebral Infarction","enrollment":244},{"nctId":"NCT00130039","phase":"PHASE4","title":"Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2005-08","conditions":"Cerebral Infarction, Atherosclerosis","enrollment":457},{"nctId":"NCT00938522","phase":"PHASE4","title":"Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2009-07","conditions":"Angioplasty, Transluminal, Percutaneous Coronary","enrollment":400},{"nctId":"NCT00272831","phase":"PHASE4","title":"The Use of Cilostazol in Patients With Diabetic Nephropathy","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2005-12","conditions":"Diabetes Mellitus, Type 2, Diabetes Complications","enrollment":62},{"nctId":"NCT00689858","phase":"PHASE1","title":"Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2007-05","conditions":"Healthy","enrollment":40},{"nctId":"NCT00300339","phase":"PHASE2","title":"Mixed Antagonist of Serotonin for Claudication Optimal Therapy","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-02","conditions":"Intermittent Claudication","enrollment":599},{"nctId":"NCT00573950","phase":"PHASE4","title":"Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness","status":"UNKNOWN","sponsor":"Korea University Anam Hospital","startDate":"2007-12","conditions":"Diabetes Mellitus, Type 2, Metabolic Syndrome X","enrollment":48}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"placebo of cilostazol","genericName":"placebo of cilostazol","companyName":"Asan Medical Center","companyId":"asan-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}